Company intelligence / Profile preview
Qualigen Therapeutics, Inc.
Carlsbad, California, United Statesqlgntx.com ↗
- Ownership
- Public · QLGN
- Employees
- ~4
- Development stage
- Phase 1
01
Overview
Currently conducting Phase 1a clinical trial for QN-302 for the treatment of pancreatic cancer and other solid tumors. Pan-RAS program is in preclinical stage.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Marizyme, Inc. (potential acquisition in progress)
Beyond the preview
Go deeper on Qualigen Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qualigen Therapeutics, Inc..